By targeting the miR-197-3p/p120 signaling axis, MALAT1 increases lung cancer cell resistance to cisplatin and cellular resistance to tetracycline, gefitinib, and paclitaxel [34]. The gene discussed is MALAT1; the disease is lung carcinoma.